1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Microvascular Angina: new trials by email Literature Review of Microvascular Angina trials Research Report on Microvascular Angina
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) Brenzavvy (bexagliflozin), 20 mg Oral Tablet, Placebo - Angina Patients With Non-obstructive Coronary Artery Disease, Coronary Microvascular Disease | Phase 1 | Recruiting | University of Virginia | 150 | 2025-07-15 | 2026-09-09 |
| Hierarchical Treatment Based on Somatization Symptom Checklist Deanxit, Prozac, coronary artery disease treatment - Syndrome X | Phase 1 / Phase 2 | Unknown | RenJi Hospital | 200 | 2015-12-01 | 2020-03-04 |
Angina Pectoris (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Myocardial Ischemia (2) · Vascular Diseases (2) · Angina Pectoris (1) · Chest Pain (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Fluoxetine (1) · Tablets (1) · bexagliflozin (1) · flupentixol, melitracen drug combination (1)
RenJi Hospital (1) · University of Virginia (1)
China (1) · United States (1)
Mao Jialiang, Docter (1) · Patricia Rodriguez-Lozano, MD (1)